Table 2. Inhibition of NOTUM activity. SAR of the amide heterocycles.
| |||||
| # | R | IC50 a (μM) | # | R | IC50 a (μM) |
| 3 |
|
33 | 21 |
|
1.6 |
| 22 |
|
9.4 | 23 |
|
3.6 |
| 24 |
|
72 | 25 |
|
100 |
| 26 |
|
0.21 | 27 |
|
0.68 |
| 28 |
|
0.33 | 29 |
|
0.24 |
| 30 |
|
0.52 | 31 |
|
0.98 |
| 32 |
|
0.36 | 33 |
|
0.27 |
| 34 |
|
0.27 | 35 |
|
0.28 |
| 36 |
|
0.20 | 37 |
|
0.068 |
| 38 |
|
0.032 | 39 |
|
0.12 |
| 40 |
|
0.44 | 41 |
|
0.27 |
| 42 |
|
7.4 | 43 |
|
2.5 |
| 44 |
|
1.2 | 45 |
|
0.085 |
| 46 |
|
0.97 | 47 |
|
0.43 |
| 48 |
|
15 | 49 |
|
0.67 |
| 50 | — | 0.069 | 51 | — | 19 |
| 52 | — | 5.2 | 53 | — | 5.7 |
| 54 | — | 7.9 | |||
aValues are geometric means of n = 2–8 experiments quoted to 2 s.f. Screening data only passed the quality control criteria if the screening plates demonstrated a Z′ > 0.5 and the NOTUM inhibition activity of the positive control was within acceptable limits (IC50 0.6–1.1 nM). Differences of <2-fold should not be considered significant. See also ESI Table S1 for s.e.m.